News Releases

News Release - Manitoba

January 21, 2021

PROVINCE ADDS 89 MEDICATIONS TO MANITOBA PHARMACARE PROGRAM

– – –
Medications Now Covered Include Treatments for Anaphylactic Reactions, Kidney Cancer, Pediatric Crohn's Disease: Minister

The Manitoba government has added 89 drugs to the provincial formulary, including 81 generic medications, Health and Seniors Care Minister Heather Stefanson announced today.
 
“Manitobans dealing with a number of conditions and disorders will now have help in paying for their prescription medications,” said Stefanson. “Medications can be costly and by adding these drugs to the formulary, we are providing better access and lessening the financial burden so patients can focus on being well.”
 
Drugs added to the formulary include:
• Emerade – for the emergency treatment of anaphylactic reactions;
• Ozempic – for the treatment of Type 2 diabetes mellitus;
• Tegsedi – for the treatment of polyneuropathy in patients with hereditary transthyretin amyloidosis;
• Triamcinolone Hexacetonide – for the treatment of pediatric chronic inflammatory arthropathies;
• Humira – for the treatment of polyarticular juvenile idiopathic arthritis and pediatric Crohn’s disease;
• Inlyta – for the treatment of kidney cancer;
• Lynparza – for the treatment of ovarian cancer;
• Xalkori – for the treatment of ROS-1 rearranged non-small cell lung cancer; and
• Try-Jordyna-21 – a generic form of a name-brand birth control pill.

Stefanson noted the drugs will be added to the provincial formulary as of today.
 
Medications being added to the formulary require patients to meet pharmacare criteria to be eligible for coverage.
 
For more information about the Manitoba Pharmacare Program, visit:
www.gov.mb.ca/health/pharmacare.

- 30 -